Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication: Clinical Efficacy Randomized Trial

NCT05664685 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT05664685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05664685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication: Clinical Efficacy Randomized Trial
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Phase 4
Overall status
Completed
Start date
October 17, 2022
Completion date
January 30, 2024
Enrollment
127 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection